Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 206 results found. Search for [ Russia's Sputnik V coronavirus vaccine ]

Results 1 to 21 of 206
Rashi Bisaria
New Delhi, June 17, 2021
COVID-19: Is there a 'Moscow strain'? Sputnik V vaccine maker believes soThere may be a new mutant of coronavirus in Russia's capital Moscow, so-called \"Moscow strain\", which may be behind the recent spike in cases in the city. The Gamaleya National Center of Epidemiology and Microbiology, which developed COVID-19 vaccine Sputnik V, is studying the effectiveness of the jab against the new strain, as per Russian state-owned news agency RIA Novosti.Microsoft CEO Satya Nadella named as chair...


BusinessToday.In
June 16, 2021
The Gamaleya National Center of Epidemiology and Microbiology, which developed COVID-19 vaccine Sputnik V, is studying the effectiveness of the jab against the new strain.


BusinessToday.In
June 10, 2021
The Pfizer-BioNTech coronavirus vaccine costs $19.5 (Rs 1,423) per dose in the US, and around $21 (Rs 1,532) a dose in the UK


BusinessToday.In
New Delhi, June 3, 2021
Pune-based Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, government sources said on Thursday. Russia's RDIF sovereign wealth fund, which is marketing Sputnik V globally, has already signed agreements with six leading Indian manufacturers including Dr Reddy's Laboratories, Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma and Virchow Biotech. The vaccine is currently being manufactured in India by Dr Reddy's Laboratories. The SII has also sought approval for test analysis and examination. Once permitted, the company will need to conduct clinical trials. Watch the video for more.Also Read: Serum Institute seeks nod for licence to manufacture Sputnik V in India


Reuters
May 27, 2021
India has been inoculating its people with the AstraZeneca vaccine produced locally at the Serum Institute, Covaxin made by local firm Bharat Biotech, and has begun rolling out Russia's Sputnik V


PTI
May 24, 2021
As announced in April, the Russian Direct Investment Fund (RDIF) - which markets the vaccine internationally, and Panacea Biotec agreed to produce 100 million doses per year of Sputnik V in India


BusinessToday.In
May 24, 2021
First batch produced at Panacea Biotec's facilities at Baddi will be shipped to the Gamaleya Centre for quality control. Full-scale production of the vaccine is due to start soon


Anwesha Madhukalya
May 17, 2021
Sputnik V has been priced at Rs 948 + 5 per cent GST per dose, amounting to Rs 995. However, the vaccine is being administered at a price of Rs 1,250 per dose at Jubilee Hills Apollo


Manoj Sharma
May 17, 2021
The current vaccine makers, Serum Institute and Bharat Biotech, alone won't be able to meet the demand. There are other players too in vaccine production, and they should be able to cater to the demand in the months ahead


BusinessToday.In
May 16, 2021
Russian Ambassador to India Nikolay Kudashev termed the delivery of the second consignment of Sputnik V vaccine in the country \"very timely\"


BusinessToday.In
New Delhi, May 15, 2021
Amid the furore over the extension of the gap between two doses of Covishield, White House chief medical adviser Dr Anthony Fauci said that it is a 'reasonable approach'; The UP government will spend up to $1.36 billion to buy COVID-19 shots and held early talks this week with companies such as Pfizer and the local partner of the maker of Russia's Sputnik V, a state official said on Thursday; Wadia Group-backed GoAir has been rebranded as 'Go First' as the airline is betting big on its ultra-low-cost business model to tide over the impact of the COVID-19 pandemic. The airline is also preparing to go for an initial public offering (IPO) to raise funds for its expansion plans. Watch this and more on News Blast.Also Read: When will international flights resume in India? Check out details


Shailendra Shukla
New Delhi, May 15, 2021
Extension of gap between Covishield doses 'reasonable approach', says Dr FauciAmid the furore over the extension of the gap between two doses of Covishield, White House chief medical adviser Dr Anthony Fauci said that it is a 'reasonable approach'. He said that if one is in a situation that India finds itself in currently, then one would have to try and figure out other ways to get as many as possible vaccinated. The comments come after the government announced on Thursday that the gap betwe...


Nidhi Singal
May 14, 2021
\"The second wave of COVID-19 calling for lockdowns and movement restrictions has had an adverse impact on the industry. The air cooler industry has witnessed loss of demand, almost a rerun of last season,\" Ravindra Singh Negi, President -- Electrical Consumer Durables, Havells India


PTI
May 14, 2021
Recently in an interview, Salman Khan had shared that his parents, veteran screenwriter Salim Khan and producer Salma Khan, got their second dose on May 9, while brother-producer Arbaaz Khan received his first shot on Sunday


PTI
May 14, 2021
The extension of one month is over and above the timelines, as prescribed under Infrastructure Investment Trusts (InvITs) and Real Estate Investment Trusts (REITs) regulations and the regulator's circulars, SEBI added


PTI
May 14, 2021
The properties in possession by the bank will be sold by way of e-auction on June 15, 2021 for recovery of Rs 345.32 crore as on April 27, 2021, YES Bank said in the notice


PTI
May 14, 2021
The decision to extend the lockdown was taken in view of high test positivity rates in districts, Chief Minister Pinarayi Vijayan said


PTI
May 14, 2021
Exports in April last year had plunged by a record 60.28 per cent due to the COVID-19 pandemic induced lockdown


BusinessToday.In
May 14, 2021
The double-dose Sputnik V was launched in the Indian market by Dr Reddy's Laboratories on Friday. The vaccine is priced at Rs 995 per dose


PTI
May 14, 2021
The Covid-19 vaccination drive has successfully completed 118 days wherein over 17.93 crore doses have been administered to identified beneficiaries through collaborative efforts of all states and UTs


PAGES 1 OF 11  12345